Insider Transactions Reported by 21 Insiders of 4D Molecular Therapeutics, Inc.

Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Emeryville, CA

Insiders trading volume in the past year

4D Molecular Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Viking Global Investors Lp 10%+ Owner $78.2M Jan 4, 2024
Ra Capital Management, L.P. 10%+ Owner $74.5M Dec 9, 2024
David Kirn Chief Executive Officer, Director $23.8M Mar 6, 2025
David Schaffer Director $16.6M Oct 20, 2021
Bvf Partners L P/Il Other* $1.44M Nov 8, 2024
Ashoo Gupta VP, Finance and Controller $397K Sep 30, 2025
August J. Moretti Chief Financial Officer $203K May 15, 2023
Scott Bizily Chief Legal Officer $38.1K -$109K -74.2% Nov 17, 2025
Carolyne Zimmermann Chief Business Officer Feb 1, 2022
Robert Fishman Chief Medical Officer Sep 1, 2022
Noriyuki Kasahara Director May 23, 2023
Robert Young Kim Chief Medical Officer Mar 6, 2025
Jacob Chacko Director Jun 17, 2025
Shawn Tomasello Director Jun 17, 2025
John F. Milligan Director Jun 17, 2025
Susannah Gray Director Jun 17, 2025
Fariborz Kamal President & COO Mar 6, 2025
Charles Theuer Director Jun 17, 2025
Nancy Miller-Rich Director Jun 17, 2025
Uneek Mehra Chief Financial & Business Officer Mar 6, 2025
Kristian Humer Chief Financial Officer Dec 9, 2025

Recent Insider Transactions by Companies or Individuals for 4D Molecular Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.